Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

E&P and Ord Minnett Issue Buy-Side Ratings on Australian Clinical Labs (ASX:ACL) with Upside Potential

Australian Clinical Labs Limited (ASX:ACL), a leading provider of healthcare facilities and pathology services, has attracted favorable analyst ratings from E&P and Ord Minnett following the release of its financial results for the year ended 30 June 2025 (FY25).

Sonal Goyal | 27 August 2025

Neuren (ASX:NEU) Reports AUD 15m Half-Year Profit and Expands NNZ-2591 Development Pipeline

Neuren Pharmaceuticals Limited (ASX:NEU) has announced its half-year financial results for the six months ended 30 June 2025 (H1 2025), reporting profit after tax ofAUD 15.0 million, up fromAUD 8.0 millionin the prior corresponding period. The increase was primarily driven by continued growth in …

Sonal Goyal | 27 August 2025

Bell Potter and Macquarie Research Back Polynovo (ASX:PNV) with Positive Ratings and Growth Outlook

Polynovo Limited (ASX:PNV), an Australian-based medical device company specialising in its patented NovoSorb® technology, has attracted favourable analyst attention following its FY25 results. Both Bell Potter Securities and Macquarie Research have reaffirmed positive views on the company.

Sonal Goyal | 26 August 2025

Ansell (ASX:ANN) Delivers Revenue and Earnings Lift; Sets FY26 Outlook

Ansell Limited (ASX:ANN), a global provider of personal protection and safety solutions, has released its financial results for the year ended 30 June 2025 (FY25), reporting revenue growth across both its Industrial and Healthcare segments.

Sonal Goyal | 25 August 2025

Bell Potter and TD Cowen Issue Buy Ratings on Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals Ltd (ASX:TLX) has received renewed confidence from two major equity research houses, withBell Potter Securities (Institutional)andTD Cowenboth issuingBuyratings on the stock.

Sonal Goyal | 22 August 2025

Cochlear (ASX:COH) Revenue Increases 4% in FY25, Eyes AUD 435–460Mn Net Profit in FY26

Cochlear Limited (ASX:COH) has released its financial results for the year ended 30 June 2025, marking a year of growth in implant sales and the launch of a major new product. In FY25, over 53,000 people received one or two of the company’s cochlear …

Sonal Goyal | 15 August 2025

The Hydration Pharmaceuticals (ASX:HPC) Launches Hydralyte Plus Metabolic Support; Share Price Rises 30%

The Hydration Pharmaceuticals Company Limited (ASX:HPC), trading as Hydralyte USA, has announced the launch of its new Hydralyte Plus Metabolic Support product, with initial sales achieved through e-commerce platforms and Amazon USA. The update saw the company’s share price rise 30% to 1.3 cents …

Sonal Goyal | 12 August 2025

Audeara (ASX:AUA) Shares Jump 31% on China Licensing Deal with Eastech

Audeara Limited (ASX:AUA) saw its share price surge31.6% to 2.5 centson Tuesday morning (12 August) after securing a landmarkLicensing Agreement with Eastech (Huizhou) Co., Ltd., a wholly owned subsidiary of Taiwan-listedEastech Holding Limited (TWSE: 5225).

Sonal Goyal | 12 August 2025

Global Health (ASX:GLH) Secures Three-Year SaaS Contract with Jarrah House

Global Health Limited (ASX:GLH)has entered into a contract with Jarrah House, a New South Wales-based alcohol and other drug (AOD) rehabilitation service, for the implementation of its cloud-based MasterCare+ Client Management System (CMS) and associated digital tools. The agreement is valued at AUD 186,748.10 …

Team Kalkine | 11 August 2025

Avita Medical (ASX:AVH) Shares Drop 23% on Q2 Miss and Medicare Payment Disruption

Shares inAvita Medical Inc (ASX:AVH)came under significant selling pressure on Friday following the release of its second-quarter results for the three months ended 30 June 2025. The regenerative medicine company’s stock opened sharply lower, dropping as much as 22.9% to an intraday low of …

Team Kalkine | 08 August 2025
Support

Hi! How can we help you today?

Loading…